Dr. Praveen Dayalu, MD

Dr. Dayalu practices at University Hospital in Ann Arbor, Michigan.

Dr. Dayalu's NPI, 1508879206, was assigned on August 14, 2006. Dr. Dayalu graduated from Cleveland Medical College, Homeopathic in 2002. Dr. Dayalu holds Michigan license 4301080297.

Dr. Dayalu's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Dayalu's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Dayalu is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Dayalu to 1 more group practice or clinic, named with a free account. Dr. Dayalu's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dayalu practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dayalu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dayalu is licensed in Michigan.

Dmand AI lists essential tremor, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, neuropathy, non-alzheimer's dementia (chronic), parkinson's disease and restless legs syndrome among the conditions Dr. Dayalu treats.

CMS data shows 404 Medicare services from Dr. Dayalu across 6 procedure codes in 2024, for 197 Medicare patients. Medicare paid $21,717 for them.

CMS counts 197 Medicare patients who saw Dr. Dayalu in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dayalu's median patient age at 70, with 53% women.

In 2024, Dr. Dayalu wrote 2,692 Medicare Part D claims for 341 patients. 93% of them were for generic drugs. CMS names the drug for 2,510 of them, across 41 drugs with 11 or more claims each, at $814,245 in total drug cost. In 2023, CMS named 2,282 claims across 37 drugs.

Dr. Dayalu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dayalu as offering telehealth.

Dmand AI links 34 papers to Dr. Dayalu, published from 2008 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Huntington Disease, Parkinson Disease and Antiparkinson Agents. Dr. Dayalu has published most often in Mov Disord. Dr. Dayalu's most frequent co-authors are Nicolaas Ida Bohnen, MD, Kelvin Lin-Yu Chou, MD and David F. Cella, PhD.

Dmand AI links Dr. Dayalu to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Huntington Disease, Chorea and Shy-Drager Syndrome.

Dmand AI lists 1 award for Dr. Dayalu, most recently CMS Stage 1 EHR in 2013.

Dr. Dayalu graduated from Cleveland Medical College, Homeopathic in 2002. Dr. Dayalu is a member of AAN.

Dr. Dayalu is in network with 21 carriers, including Aetna, Excellus BlueCross BlueShield and Health Alliance Plan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.